Inspection Record

Sun Pharma Canada Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-02-01 6 findingsComplaint and recall handlingOther quality systemDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Complaint and recall handling

The company's oversight of the contracted party was inadequate. Investigations into deviations, reports, and/or follow-up actions were inadequate. The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

2Other quality system

The recorded information or details were inadequate. The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.

3Other quality system

Measures to ensure the compliance of the contracted test laboratories were inadequate.

4Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

5Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

6Other quality system

The implementation of a self-inspection program was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-02-01. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Sun Pharma Canada Inc. findings history — including this company's other documents Health Canada documents, 2022 Go to Findings search